The Transhumanist Posts

04/22/2018 / / Transhumanism
04/15/2018 / / Biotechnology
04/07/2018 / / Biotechnology
04/02/2018 / / Transhumanism

Atomwise, that uses deep learning for shortening the process of discovering drug discovery of new drugs has raised $45 million Series A. Monsanto Growth Ventures raised the round; Data Collective (DCVC) and B Capital Group. Baidu Ventures, Tencent, and Dolby Family Ventures were also included. All of these ventures are new investors in Atomwise, that have also participated and there were also some returning investors like Y Combinator, Khosla Ventures, and DFJ. Read the Post Atomwise Raises $45M by Using AI to Improve Drug Discovery

03/25/2018 / / Biotechnology

Summary: One of the startups is trying to develop bioprinted hearts¬†using the stem cells from a patient’s own body with the help of a 3D bioprinter.

The startup called BioLife4D is looking forward to developing the bioprinted beating hearts using the patient’s own cells that would later work as a potential solution for the patients seeking the heart transplant. Read the Post Bioprinted new beating hearts to replace our diseased ones.